Biomarin Pharmaceutical Inc. (BMRN)
$68.96
Biomarin Pharmaceutical Inc. (BMRN) Share Price Forecast
Currently 35 wall-street analysts regularly analyze the financials of Biomarin Pharmaceutical Inc. on a frequent basis to provide recommendations along with target share price. 35 analysts offering 12-month price forecasts for Biomarin Pharmaceutical Inc. (BMRN) have a share price target of $102.45. This median of share price forecast represents a 48.56% upside from the latest price of $68.96 as on 08.10.24.
Biomarin Pharmaceutical Inc. (BMRN) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Biomarin Pharmaceutical Inc. (BMRN) share price will touch around $102.45 in next 12-months.
Biomarin Pharmaceutical Inc. (BMRN) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Biomarin Pharmaceutical Inc.'s share price and its median forecast price. As on 08.10.24, the difference is -31.58%
Biomarin Pharmaceutical Inc. (BMRN): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Biomarin Pharmaceutical Inc. (BMRN) Share Price : Analyst Recommendation
Based on 35 analysts tracking and researching Biomarin Pharmaceutical Inc. (BMRN) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 15 | 15 | 16 |
| Outperform | 10 | 10 | 10 |
| Hold | 10 | 9 | 9 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Biomarin Pharmaceutical Inc. (BMRN) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Biomarin Pharmaceutical Inc. (BMRN) is $102.45, offered by 35 analysts offering 12-month price forecasts.
Biomarin Pharmaceutical Inc. (BMRN) has a maximum of 0.49 upside potential, based on 35 analysts offering 12-month price forecasts.
Based on 35 analysts tracking and researching Biomarin Pharmaceutical Inc. (BMRN), 74.29% have a buy recommendation. Remaining 25.71% have either sell or hold recommendations.
The latest share price of Biomarin Pharmaceutical Inc. (BMRN) is $68.96 as of 08/10/2024.
26 of total 35 analysts offering stock ratings for Biomarin Pharmaceutical Inc. BMRN have recommended buy rating.
₹0 US Stocks a/c Opening Fee